What is BrainCheck?
BrainCheck operates as a clinically validated digital platform specializing in cognitive assessment and care management. Its flagship offering, BrainCheck Assess, is an FDA Class II medical device that provides standardized, repeatable cognitive data, enabling clinicians to move beyond subjective evaluation. By integrating structured screening tools with personalized care planning, the platform serves as a vital technology-driven complement to professional medical evaluation. The company's market position is defined by its ability to bridge the gap between research-grade cognitive data and practical, clinical decision-making, thereby enhancing patient outcomes across diverse healthcare settings.
How much funding has BrainCheck raised?
BrainCheck has raised a total of $39.2M across 9 funding rounds:
Private Equity
$2.2M
Angel/Seed
$1.2M
Unspecified
$1.5M
Series A
$8M
Debt
$150K
Debt
$338K
Series B
$10M
Other Financing Round
$15M
Private Equity (2016): $2.2M, investors not publicly disclosed
Angel/Seed (2017): $1.2M supported by True Wealth Ventures
Unspecified (2018): $1.5M featuring S3 Ventures, Tensility Venture Partners, True Wealth Ventures, and XFactor Ventures
Series A (2019): $8M backed by Tensility Venture Partners, Nueterra Capital, True Wealth Ventures, and S3 Ventures
Debt (2020): $150K with participation from PPP
Debt (2021): $338K led by PPP
Series B (2021): $10M supported by Nueterra Capital, Tensility Venture Partners, Next Coast Ventures, and S3 Ventures
Other Financing Round (2024): $15M featuring S3 Ventures and Next Coast Ventures
Key Investors in BrainCheck
S3 Ventures
S3 Ventures is a prominent Austin-based venture capital firm that provides patient, flexible capital to high-impact startups in the healthcare technology and business software sectors.
Next Coast Ventures
Next Coast Ventures is an early-stage investment firm that partners with bold entrepreneurs in high-growth markets, offering hands-on operational support and deep industry networks.
Tensility Venture Partners
Tensility Venture Partners is a specialized venture capital firm focused exclusively on AI-first software and deep tech applications that transform traditional industries.
What's next for BrainCheck?
With the successful closure of this major strategic investment, BrainCheck is well-positioned to accelerate its product roadmap and expand its footprint in the digital health ecosystem. The company is expected to focus on scaling its clinical adoption, enhancing its data analytics capabilities, and deepening its integration with existing electronic health record systems. As the demand for objective, technology-enabled cognitive health solutions continues to rise, BrainCheck's strategic focus will likely center on broadening its reach within large-scale healthcare networks and research institutions, ensuring that its validated protocols become the standard for cognitive health monitoring and longitudinal care management.
See full BrainCheck company page
